Skip to content
aiqbench takeAI Research

aiqbench analysis

This study highlights a critical structural disconnect in medical AI research, where the rapid obsolescence of large language models creates an evaluation lag that compromises both rigor and currency. The findings reveal that randomized trials frequently assess discontinued or significantly older model families, suggesting that methodological constraints are driving researchers to use outdated systems rather than simply delaying publication. For the AI community, this underscores the urgent need for standardized evaluation frameworks that can adapt to fast-moving model cycles without sacrificing clinical validity.
Sources coveringarXiv, LessWrong
What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

The widening evaluation gap in medical large language model research 2023 to 2026

arXiv2 min read

arXiv:2609.11770v1 Announce Type: new Abstract: Large language models are superseded every few quarters; clinical evidence takes years. We asked whether medical research is keeping pace with the systems it evaluates. PubMed returned 11,628 records for January 2023 to June 2026 across fourteen clinical domains, growing 45-fold; 2.5% used a randomised, controlled or prospective design. Evaluation lag, from a study's newest named model release to its own publication, widened from 1.33 to 6.08 quarters. Because discontinued models age mechanically, we benchmarked this against a counterfactual holding model composition fixed: migration to newer systems offset only 56% of the drift (95% CI 50-65). Randomised trials evaluated models a median 4.6 quarters older than other designs (P = 3 x 10^-19), yet among studies naming a model still under development no design differed from any other; 62% of randomised trials evaluated a discontinued family. Rigour and currency are in tension, and that tension reflects model selection rather than research timelines.

Abstract:Large language models are superseded every few quarters; clinical evidence takes years. We asked whether medical research is keeping pace with the systems it evaluates. PubMed returned 11,628 records for January 2023 to June 2026 across fourteen clinical domains, growing 45-fold; 2.5% used a randomised, controlled or prospective design. Evaluation lag, from a study's newest named model release to its own publication, widened from 1.33 to 6.08 quarters. Because discontinued models age mechanically, we benchmarked this against a counterfactual holding model composition fixed: migration to newer systems offset only 56% of the drift (95% CI 50-65). Randomised trials evaluated models a median 4.6 quarters older than other designs (P = 3 x 10^-19), yet among studies naming a model still under development no design differed from any other; 62% of randomised trials evaluated a discontinued family. Rigour and currency are in tension, and that tension reflects model selection rather than research timelines.

Computation and Language (cs.CL)

arXiv:2609.11770 [cs.CL]

(or arXiv:2609.11770v1 [cs.CL] for this version)

https://doi.org/10.48550/arXiv.2609.11770 Focus to learn more arXiv-issued DOI via DataCite (pending registration)

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Full text under the publisher's open licence · 247 words

Related coverage